
Forbes @Forbes
If data from the 2 to 5 age group trials is promising, the company says it will proceed with regulatory filings to seek approval from the FDA https://t.co/01ONjTf2GC — PolitiTweet.org
Created
Thu Jan 13 16:32:06 +0000 2022
Likes
39
Retweets
10
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely AvailableForbes @Forbes
If data from the 2 to 5 age group trials is promising, the company says it will proceed with regulatory filings to seek approval from the FDA https://t.co/01ONjTf2GC — PolitiTweet.org